Herbert Yu

Insulin‐like growth factors (IGF‐I, free IGF‐I, and IGF‐II) and insulin‐like growth factor binding proteins (IGFBP‐2, IGFBP‐3, IGFBP‐6, and ALS) in blood circulation

A. Juul, J. van Doorn, M. Nicar, 1999, Journal of clinical laboratory analysis.

Role of the insulin-like growth factor family in cancer development and progression.

T. Rohan, H Yu, T Rohan, 2000, Journal of the National Cancer Institute.

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

M. Spitz, W. Hong, Xifeng Wu, 1999, Journal of the National Cancer Institute.

The relation of type 2 diabetes and cancer.

T. Rohan, R. Burk, D. Hoover, 2001, Diabetes technology & therapeutics.

Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy.

Benjamin D. L. Li, G. Burton, J. Mcdonald, 2000, Annals of surgery.

Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.

J. Trachtenberg, E. Diamandis, R. Shi, 2001, Urology.

Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.

M. Spitz, W. Hong, Xifeng Wu, 2000, Journal of the National Cancer Institute.